<DOC>
	<DOCNO>NCT00107848</DOCNO>
	<brief_summary>The primary objective study evaluate safety tolerability treatment PROVIGIL child adolescent excessive sleepiness ( ES ) associate narcolepsy OSAHS ( obstructive sleep apnea/hypopnea ) , administer 12 month . Safety tolerability evaluate throughout study mean adverse event information , clinical laboratory test result , vital sign measurement , body weight height measurement ; quarterly physical examination finding ; 12 lead electrocardiograph ( ECG ) evaluation end study . In addition , cognitive behavioral effect PROVIGIL assess quarterly measure Child Behavior Checklist Ages 6-18 ( CBCL/6-18 ) , brief psychiatric interview , Kaufman Brief Intelligence Test ( KBIT 2 ) .</brief_summary>
	<brief_title>PROVIGILÂ® ( Modafinil ) Treatment Children Adolescents With Excessive Sleepiness Associated With Narcolepsy Obstructive Sleep Apnea/Hypopnea Syndrome</brief_title>
	<detailed_description>PROVIGIL register trademark Genelco , S.A. , license Cephalon , Inc .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Appropriate write assent obtain patient write informed consent obtain parent legal guardian ( defined IEC/IRB ) A boy girl age 6 16 year ( start previous double blind study ) , inclusive , participate study C1538/3027/NA/MN C1538/3028/AP/MN Have diagnosis ( establish previous double blind study ) narcolepsy ( presumed narcolepsy ) OSAHS accord criterion establish International Classification Sleep Disorders ( ICSD ) manual American Academy Sleep Medicine ( AASM ) Continue good health determine medical psychiatric history , ECGs , physical examination finding , serum chemistry , hematology , urinalysis Have blood pressure value great 5th percentile less 95th percentile National High Blood Pressure Education Program guideline blood pressure level boys girl age 6 16 year Girls post menarche sexually active negative urine pregnancy test screening/baseline visit , must use medically acceptable method birth control , must agree continue use method duration study ( 30 day participation study ) . Acceptable method birth control include : barrier method spermicide ; steroidal contraceptive ( oral , topical [ patch ] , implant , inject ) conjunction barrier method ; intrauterine device ( IUD ) ; abstinence No positive urine drug screen ( UDS ) illicit drug alcohol ( ethanol ) baseline visit , unless false positive suspect , case UDS repeat . If patient positive drug screen methylphenidate amphetamine screening , patient must negative UDS washout period prior baseline . Have parent legal guardian willing participate study Continue meet inclusion criterion previous study , appropriate Have self induced sleep deprivation/poor sleep hygiene Have past present seizure disorder ( except history single febrile seizure ) , history psychosis , clinically significant head trauma ( eg , brain damage ) past neurosurgery Have history suicide attempt , suicidal risk A clinically significant drug sensitivity stimulant amphetamine , dextroamphetamine , methylphenidate , pemoline ; modafinil component Any disorder could interfere drug absorption , distribution , metabolism , excretion ( include previous gastrointestinal surgery ) Active , clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematologic , neoplastic , endocrine , neurologic , immunodeficiency , pulmonary , major clinically significant disorder/disease Any clinically significant deviation normal range ( ) ECG physical examination finding , clinical laboratory ( ie , hematology , serum chemistry , urinalysis ) test result screening/baseline visit Absolute neutrophil count ( ANC ) low limit normal baseline visit ( NOTE : If ANC low limit normal baseline visit , medical monitor consult continued eligibility study . ) A seat pulse outside range 60 115 bpm rest 5 minute A total daily intake 500 mg caffeine per day ( eg , approximately ten 12 ounce caffeinated soda , 5 cup coffee tea , 25 ounce chocolate per day ) within 1 week baseline visit Pregnant lactating/nursing ; child becomes pregnant study withdrawn .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Pediatric Narcolepsy</keyword>
	<keyword>Pediatric OSA</keyword>
	<keyword>CPAP</keyword>
	<keyword>Pediatric Narcolepsy OSAHS</keyword>
</DOC>